CD8A and myeloid sarcoma: Moreover, patients in non-DMT-NMOSD group had significantly higher levels of PLT counts and PLR as well as lower levels of CD4/CD8, eosinophils, basophils, and CD3+CD4+ T cells in both counts and proportions than patients with acute MS.